Skip to Main Content

Hello, everyone, and how are you today? We are doing much better, thank you very much, now that the municipal work crew has departed, which allows the Pharmalot campus to be restored to its usual serene state. The official mascots are especially happy since they can snooze comfortably once again. And we are celebrating with a cup of delicious stimulation — cinnamon coffee roll, if you must know. Meanwhile, here are some tidbits. Enjoy your day and do drop us a line when something juicy arises. We will not allow spy agencies to learn your identity …

Valeant Pharmaceuticals reached a deal to sell its iNova Pharmaceuticals unit for $930 million, the latest attempt by the beleaguered drug maker to rid itself of a burdensome debt load, the Wall Street Journal notes. iNova, which operates in more than 15 countries, sells prescription and over-the-counter products in areas such as weight management, pain management, cardiology, and cough and cold.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!